Faculty

Institution

Unit

Venue

Eduardo Vilar-Sanchez

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Clinical Cancer Genetics

Department Of Clinical Cancer Prevention, 1515 Holcombe Blvd. Unit 1360

Department Of Clinical Effectiveness

Division Of Cancer Prevention And Population Sciences

The University of Texas MD Anderson Cancer Center

NoneEduardo Vilar-sanchez is currently serving as a Clinical Cancer Genetics faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Eduardo Vilar-Sanchez

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology cancer research colorectal cancer pharmacology molecular cancer immunology oncogenes molecular diagnostics cancer genetics medicine cancer care medicinal research cancer biology immunotherapy cancer cells cancer discovery cancer genomics radiation oncology biomarkers clinical research clinical investigation cancer treatment pancreatic cancer cellular immune responses randomized presurgical trial biomarker tissue levels hereditary cancer syndromes proteomics preventive healthcare tumor biology surgical oncology cellular therapy cancer imaging cancer letter molecular gastroenterology family psychology supportive care immune checkpoint inhibitors early detection tumor targeting liver cancer therapeutic efficacy drug trials cancer risk variant interpretation antigen processing t-regulatory cell immunological biomarkers disease progression anti-cancer agents pancreatic surgery cancer immunosurveillance immunomodulation therapeutic vaccines molecular pathology cancer prevention gastrointestinal oncology patient support genetic counseling tumor subtypes oncogenic mutations radiotherapy-induced immune priming atr-mediated cd47 preclinical model sulindac dosing regimens small intestine colorectal cancer prevention familial adenomatous polyposis placebo-controlled study exemestane alternative schedules high prevalence early-onset pancreatic cancer

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 963: Preclinical Testing of A2B Adenosine Receptor Inhibitor Psb1115 for Pancreatic Cancer Immunoprevention. Cancer Research (2026)

cancer immunotherapyimmunologymedicinal researchabstract 963molecular cancerpancreatic cancer immunopreventioncancer researchpancreatic cancerpharmacologypreclinical testingcancer cellspancreatic surgeryoncology

Optimization of Mhealth Behavioral Intervention for Families With Hereditary Breast and Ovarian Cancers: The Health4Families Study. Medicine & Science in Sports & Exercise (2025)

genetic counselingpublic healthbehavior change (public health)mhealth behavioral interventionhereditary breasthealth4families studypatient supportfamily psychologysupportive carefamily medicinecancer carebreast cancer

Abstract Ps07-01: Exemestane and Breast Cancer Prevention: How Low Can We Go? Drug and Biomarker Tissue Levels in a Randomized Presurgical Trial on Exemestane Alternative Dosing Regimen. Cancer Research (2024)

Davide SerranoHarriet JohanssonBjørn-Erik BertelsenGunnar MellgrenParijatham ThomasKatherine CrewNagi B KumarDebora MacisValentina AristarcoAliana Guerrieri GonzagaSara GandiniMauro D’AmicoTania Buttiron WebberIrene Maria BriataStefano SpinaciViviana GalimbertiGiuseppe VialeLana A. VornikEduardo Villar-SanchezPowel BrownBrandy M Heckman-StoddardEva SzaboBernardo BonanniAndrea De Censi

biomarker tissue levelscancer preventioncancer researchmedicinepharmacologyrandomized presurgical trialhealth sciencesoncologycancer biology

Drug and Biomarker Tissue Levels in a Randomized Presurgical Trial on Exemestane Alternative Schedules. JNCI Journal of the National Cancer Institute (2024)

Davide SerranoHarriet JohanssonBjørn-Erik BertelsenSara GandiniGunnar MellgrenParijatham ThomasKatherine D CrewNagi B KumarDebora MacisValentina AristarcoAliana Guerrieri-GonzagaMatteo LazzeroniMauro D’AmicoTania Buttiron-WebberIrene Maria BriataStefano SpinaciViviana GalimbertiLana A VornikEduardo Villar-SanchezPowel H BrownBrandy M Heckman-StoddardEva SzaboBernardo BonanniAndrea DeCensi

biomarker tissue levelsexemestane alternative schedulesdrug trialspharmacologybiomarkersrandomized presurgical trialclinical trials

Su1130 Delphi Initiative for Early-Onset Colorectal Cancer (Direct). International Management Guidelines on Behalf of Cga-Igc, Ehtg, Insight, and Aifet. Gastroenterology (2023)

Giulia M. CavestroAlessandro MannucciFrancesc BalaguerHeather HampelSonia S. KupferAlessandro RepiciAndrea Sartore-BianchiToni T SeppäläVincenzo ValentiniClement R. BolandRandall BrandTineke E. BuffartCarol A. BurkeRiccardo CaccialanzaRenato CannizzaroStefano CascinuAndrea CercekEmma J CrosbieSilvio DaneseEvelien DekkerMaria Daca-AlvarezFrancesco DeniMev Dominguez-Valentincathy engAjay Goeljose g. guillemBritt B. HouwenCharles KahiMatthew KaladyFay KastrinosFlorian KühnLuigi LaghiAndrew LatchfordDavid LiskaPatrick M. LynchAlberto MalesciGianluca MauriElisa MeldolesiPål M⊘llerKevin J. MonahanGabriela MösleinCaitlin C. MurphyKarlijn J. NassKimmie NgCristina OlianiEnrico PapaleoSwati G PatelMarta PuzzonoAndrea RemoLuigi RicciardielloCarla Ida RipamontiSalvatore SienaSatish K SinghZsofia StadlerPeter P. StanichSapna SyngalStefano TuriEmanuele Damiano luca UrsoLaura ValleValeria S. VanniEduardo Vilar SanchezMarco VitellaroY. Nancy YouMatthew B.B. YurgelunRaffaella Alessia ZuppardoElena M. Stoffel

health policypublic healthcolorectal cancergastroenterologyinternational management guidelinesmedicineearly-onset colorectal canceroncology

28 Identification and Functional Validation of Neoantigens-Specific T-Cell Receptors in Lynch Syndrome. Regular and Young Investigator Award Abstracts (2022)

Fahriye DuzagacKrishna SinhaAna BolivarNan DengLaura Reyes UribeAlexandre ReubenEduardo Vilar-Sanchez

pathologylynch syndromet-regulatory cellimmunologymedicinal researchclinical investigationvariant interpretationneuroimmunologyfunctional validationimmune responsescellular immune responsesmolecular biologyautoimmune diseasesantigen processingautoimmunityreceptorsneoantigens-specific t-cell receptors

36 Analysis of T-Cell Receptor Sequences Identifies Signatures Associated With Neoantigen Exposure in Peripheral Blood of Lynch Syndrome Patients. Regular and Young Investigator Award Abstracts (2022)

Ana BolivarEduardo Vilar-SanchezKrishna SinhaLaura Reyes UribeNan DengFahriye DuzagacAlexandre Reuben

gene expressionimmunological biomarkerst-cell receptor sequencespathologyneoantigen exposurepathogenesisimmunologydisease progressionclinical investigationneuroimmunologylynch syndrome patientscellular immune responsesperipheral bloodautoimmunityreceptorsgenetics

Abstract Ia018: Cancer Immune-Interception in Lynch Syndrome: Neoantigen-Based Vaccine Development. Cancer Prevention Research (2022)

oncogenespathologyvaccinescancer immunotherapyimmunologyimmunotherapymolecular cancerimmunomodulationcancer researchimmune responsesmolecular diagnosticscancer discoveryautoimmune diseasescancer immunosurveillanceabstract ia018cancer cellstherapeutic vaccines

Abstract Ia026: Novel Insights Into Colorectal Pre-Cancers From Hereditary Cancer Syndromes: From Omics to Interception. Cancer Research (2022)

oncogenescolorectal cancerpathologymolecular pathologyhereditary cancer syndromesnovel insightsmolecular cancercancer researchmolecular diagnosticscancer discoverymolecular gastroenterologyabstract ia026human geneticsomicscancer geneticscancer genomicsgenetics

592 Atr-Mediated Cd47 and Pd-L1 Upregulation Restricts Radiotherapy-Induced Immune Priming and Abscopal Responses in Colorectal Cancer. Regular and Young Investigator Award Abstracts (2021)

oncogenescolorectal cancerradiation oncologyatr-mediated cd47immunologyimmunotherapycellular therapyimmune checkpoint inhibitorsoncologyradiotherapy-induced immune priming

1
2
10 / page

Eduardo Vilar-Sanchez

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Clinical Cancer Genetics

Department Of Clinical Cancer Prevention, 1515 Holcombe Blvd. Unit 1360

Department Of Clinical Effectiveness

Division Of Cancer Prevention And Population Sciences

The University of Texas MD Anderson Cancer Center

NoneEduardo Vilar-sanchez is currently serving as a Clinical Cancer Genetics faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Eduardo Vilar-Sanchez

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 963: Preclinical Testing of A2B Adenosine Receptor Inhibitor Psb1115 for Pancreatic Cancer Immunoprevention. Cancer Research (2026)

Optimization of Mhealth Behavioral Intervention for Families With Hereditary Breast and Ovarian Cancers: The Health4Families Study. Medicine & Science in Sports & Exercise (2025)

biomarker tissue levelscancer preventioncancer researchmedicinepharmacologyrandomized presurgical trialhealth sciencesoncologycancer biology

Drug and Biomarker Tissue Levels in a Randomized Presurgical Trial on Exemestane Alternative Schedules. JNCI Journal of the National Cancer Institute (2024)

biomarker tissue levelsexemestane alternative schedulesdrug trialspharmacologybiomarkersrandomized presurgical trialclinical trials

Su1130 Delphi Initiative for Early-Onset Colorectal Cancer (Direct). International Management Guidelines on Behalf of Cga-Igc, Ehtg, Insight, and Aifet. Gastroenterology (2023)

health policypublic healthcolorectal cancergastroenterologyinternational management guidelinesmedicineearly-onset colorectal canceroncology

28 Identification and Functional Validation of Neoantigens-Specific T-Cell Receptors in Lynch Syndrome. Regular and Young Investigator Award Abstracts (2022)

Fahriye DuzagacKrishna SinhaAna BolivarNan DengLaura Reyes UribeAlexandre ReubenEduardo Vilar-Sanchez

Ana BolivarEduardo Vilar-SanchezKrishna SinhaLaura Reyes UribeNan DengFahriye DuzagacAlexandre Reuben

Abstract Ia018: Cancer Immune-Interception in Lynch Syndrome: Neoantigen-Based Vaccine Development. Cancer Prevention Research (2022)

Abstract Ia026: Novel Insights Into Colorectal Pre-Cancers From Hereditary Cancer Syndromes: From Omics to Interception. Cancer Research (2022)

592 Atr-Mediated Cd47 and Pd-L1 Upregulation Restricts Radiotherapy-Induced Immune Priming and Abscopal Responses in Colorectal Cancer. Regular and Young Investigator Award Abstracts (2021)

oncogenescolorectal cancerradiation oncologyatr-mediated cd47immunologyimmunotherapycellular therapyimmune checkpoint inhibitorsoncologyradiotherapy-induced immune priming

1
2
10 / page